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The Epstein–Barr virus (EBV)-positive B958 cell line expresses two related membrane proteins encoded by BNLF-1 open
reading frames. One protein (LMP-1) has been shown to be essential for the growth transforming properties of EBV. The
second protein (the lytic LMP-1) is an amino-terminally truncated form of LMP-1 whose expression is associated with
induction of EBV’s lytic cycle. We have investigated the expression of full-length and lytic forms of LMP-1 immediately after
infection of the EBV-negative, B-lymphoma cell line BJAB. Only the lytic LMP-1 protein is present in BJAB cells early (within
minutes following addition of virus) after infection with virus derived from either uninduced or tetradecanoyl phorbol acetate
and sodium butyrate-induced B958 cells. Lytic LMP-1 protein levels begin to decline by 48 hr after infection, whereas levels
of full-length LMP-1 increase between 24 and 48 hr after infection and then remain constant. The presence of the lytic
LMP-1 protein in infected cells is independent of both protein synthesis and virus internalization. We also find the lytic
LMP-1 protein in BJAB cells early after infection (within 3 hr of addition of virus) with the HH514 strain of EBV, and HH514
cells treated with tetradecanoyl phorbol acetate and sodium butyrate, express high levels of both the lytic LMP-1 and full-
length LMP-1 proteins. The lytic LMP-1 protein is enriched in purified virion preparations, and immunoelectron microscopic
analysis indicates that EBV virions can be specifically labeled with anti-LMP-1 antisera. Together, these results are consistent
with a model in which the lytic LMP-1 protein is present in the EBV virion and is carried into the B-cell upon infection and
suggest a role for this protein in early infection events and/or in EBV’s lytic cycle. q 1997 Academic Press
INTRODUCTION al., 1986; Mann et al., 1985) and partially associates with
the detergent-insoluble cytoskeleton (Liebowitz et al.,
Epstein–Barr virus (EBV) is a human herpesvirus asso-
1987; Mann and Thorley-Lawson, 1987). In addition, LMP-
ciated with African Burkitt’s lymphoma, nasopharyngeal
1 has a turnover rate of approximately 2 hr (Mann and
carcinoma, Hodgkin’s disease, and B-cell lymphomas
Thorley-Lawson, 1987; Baichwal and Sugden, 1987; Mar-
(Miller, 1985). EBV infects resting human B-cells and es-
tin and Sugden, 1991b) and its carboxy-terminus is phos-
tablishes a latent infection. These latently infected cells
phorylated on serine and threonine residues (Mann and
enter the cell cycle, proliferate indefinitely, and thus are
Thorley-Lawson, 1987; Baichwal and Sugden, 1987).
immortalized. The latent membrane protein (LMP-1), 1 of
LMP-1 induces anchorage-independent and tumorigenic
10 viral gene products expressed in the latently infected
growth of rodent cells (Baichwal and Sugden, 1988;
cell, has been shown to be essential for the process of Wang et al., 1988). Expression of LMP-1 in certain B-cell
immortalization (Kaye et al., 1993). The LMP-1 gene lies lines alters their surface phenotype (Henderson et al.,
in the BamHI N region of the EBV genome, and the mRNA 1991; Wang et al., 1988, 1990) and activates NF-kB (Ham-
encoding LMP-1 arises from the EDL1 promoter (Hudson merskjold and Simurda, 1992; Laherty et al., 1992). When
et al., 1985) (Fig. 1). The predicted structure of the LMP- expressed at high levels in most cell types, LMP-1 is
1 protein includes a short, 25 amino acid intracellular cytotoxic (Hammerschmidt et al., 1989). Recent evidence
amino-terminus, followed by six transmembrane do- suggests that LMP-1 binds to TRAF (Tumor necrosis fac-
mains and a large acidic intracellular carboxy-terminus tor-associated factors) family members via its carboxy-
(Liebowitz et al., 1986). LMP-1 has a predicted molecular terminus (Mosialos et al., 1995), adding to the myriad of
weight of 42 kDa but migrates with an apparent molecu- possible mechanisms through which LMP-1 might func-
lar weight of 62–65 kDa on SDS–PAGE gels. The LMP- tion in B-cell immortalization.
1 protein is primarily associated with the plasma mem- A second LMP-1 open reading frame lies within the
brane (Fennewald et al., 1984; Hennessy et al., 1984; BamHI N region of the LMP-1 gene (Hudson et al., 1985).
Mann et al., 1985), where it is aggregated (Liebowitz et The mRNA encoded by this second open reading frame
(ORF) arises from the activity of the EDL1A promoter
which is located within the first intron of the LMP-1 gene1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (303) 492-1587. E-mail: jm@colorado.edu. (Hudson et al., 1985) (Fig. 1). The protein expressed from
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protein (Wang et al., 1988). At this time, the function of
the lytic LMP-1 protein remains unknown.
Interestingly, EBV encodes an amino-terminally trun-
cated version of its second membrane protein, LMP-2A
(Sample et al., 1989). LMP-2A is a polytopic membrane
protein possessing twelve predicted transmembrane do-
mains, with amino- and carboxy-termini predicted to be
located within the cytoplasm (Sample et al., 1989). LMP-
2B, which arises from its own promoter (Sample et al.,
1989), lacks the 119 amino-terminal residues of LMP-
2A that are responsible for coupling to protein tyrosineFIG. 1. Schematic representation of the BamHI N region of the EBV
genome, indicating the two promoters, EDL1 and EDL1A, and the kinases involved in cellular signaling pathways (Long-
mRNAs which arise from each promoter. The numbering (168 kb) indi- necker et al., 1991). While LMP-2A blocks reactivation
cates the position in the EBV genome, and ‘‘TR’’ represents the terminal of the virus productive cycle by interfering with antigenrepeats in EBV. The latent, full-length LMP-1 gene, consisting of 3
receptor signaling (Miller et al., 1994), the function ofexons and 2 introns, is expressed during the latent phase of EBV’s life
LMP-2B is still unknown. One noteworthy difference be-cycle. Expression of the late, truncated LMP-1 transcript is associated
with induction of the lytic cycle. The putative structures of encoded tween the truncated versions of LMP-1 and LMP-2A is
protein products are shown to the right of the corresponding mRNAs. that LMP-2B is expressed during the latent phase of
EBV’s life cycle, whereas expression of the lytic LMP-1
protein is associated with induction of the lytic cycle.the EDL1A transcript has an observed molecular weight
of 45 kDa and is an amino-terminally truncated form of Thus, EBV has evolved to encode amino-terminally trun-
cated forms of each of its membrane proteins and neitherthe LMP-1 protein. Initiation is predicted to occur at me-
thionine-129 of the full-length protein prior to LMP-1’s truncated protein (lytic LMP-1 nor LMP-2B) has an identi-
fied function.fifth predicted transmembrane domain (Hudson et al.,
1985). The truncated form of LMP-1 has been termed the The dramatic differences in biochemical and biological
properties between the lytic and full-length LMP-1 pro-‘‘lytic LMP-1’’ because its expression (mRNA/protein) is
upregulated upon induction of the lytic cycle in B958 cells teins, despite their identity in sequence, suggests
strongly that the lytic LMP-1 protein has a function in theby treatment with tetradecanoyl phorbol acetate (TPA)
and sodium butyrate (Baichwal and Sugden, 1987). The infected cell that is distinct from that of the full-length
LMP-1. In an attempt to gain insights into possible func-expression of the lytic LMP-1 protein correlates well with
the virus producer status of the infected cell. Permissive tions for the lytic LMP-1 protein in the virus life cycle, we
have undertaken a series of experiments designed tocell lines such as B958 which spontaneously release
virus and in which the efficiency of virus release can be characterize the kinetics of expression of both forms of
LMP-1 following B-cell infection by EBV. The results offurther enhanced by treatment with agents that induce
the lytic cycle (i.e., TPA and butyrate), express the lytic these experiments are consistent with the model that the
lytic LMP-1 protein preexists in the virion and is therebyLMP-1 protein, and this ‘‘basal’’ expression is induced
upon lytic cycle induction (Baichwal and Sugden, 1987; carried into the B-cell upon infection. We found no evi-
dence suggesting the presence of the full-length LMP-1Boos et al., 1987; Hudson et al., 1985; Rowe et al., 1987).
Although the lytic LMP-1 protein is identical in se- protein in the virion. These results suggest a role for the
lytic LMP-1 protein shortly after infection and/or in thequence to the last 257 residues of the full-length protein,
the two proteins share no common biological or bio- lytic phase of EBV’s life cycle.
chemical activities. Genetic analyses of amino-terminally
truncated mutants of LMP-1 have shown that the lytic MATERIALS AND METHODS
LMP-1 protein does not transform rodent cells (Baichwal
Cells
and Sugden, 1989; Wang et al., 1988), is not cytotoxic
when expressed at high levels in cells (Hammerschmidt BJAB, an EBV-negative B-lymphoma cell line, was
grown in RPMI plus 10% fetal bovine serum (Hyclone)et al., 1989), does not alter the cell surface phenotype of
B-cells (Wang et al., 1988), and is deficient, relative to (R10F). B958, a marmoset B-cell line transformed in vitro
by EBV (Miller and Lipman, 1973), and HH514, a subclonefull-length LMP-1, in its ability to induce NF-kB activity
(Huen et al., 1995; Mitchell and Sugden, 1995). In addi- of the P3HR1 EBV-positive BL cell line harboring a non-
transforming strain of EBV, were maintained in RPMI plustion, the lytic LMP-1 protein, unlike the full-length LMP-
1 protein, is not associated with the cytoskeleton, frac- 10% bovine calf serum (R10C). All cells were grown in
the presence of 100 U of penicillin and 200 mg of strepto-tionates both with the particulate and soluble fractions
of broken cells, and does not localize in discrete patches mycin per milliliter at 377 in a humidified atmosphere of
4% CO2 .in the plasma membrane as does the full-length LMP-1
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Plasmids carbonic anhydrase (36 kDa), myoglobin (30 kDa), lyso-
zyme (16 kDa), aprotinin (6 kDa), insulin b chain (4 kDa).
p2036.1 is a bacterial expression vector encoding a The migration of molecular weight markers is indicated
GST-LMP fusion protein and was generated by insertion by horizontal bars in each figure; those markers shown
of a blunt-ended NcoI fragment of the LMP-1 gene (en- in each figure were selected because their migration
coding residues 187–352 of LMP-1) into the SmaI site brackets the migration of the LMP-1 proteins; the 64-kDa
of pGEX 3X (Pharmacia). marker was included in a subset of figures to illustrate
the position of the cross-reacting protein.
Virus preparations
Purification of virusVirus was obtained from B958 and HH514 cells. Briefly,
cells were grown to saturation (106 cells per ml) and then Virus was purified from 5 liters of TPA/butyrate-treated
maintained in the presence of 20 ng/ml TPA and 3.5 mM B958 cell supernatant using a combination of methods
sodium butyrate for 5 days. Cellular debris was removed described previously (Nemerow and Cooper, 1981) and
from cell supernatants by centrifugation (200 g) and su- (Spear and Roizman, 1972). Briefly, B958 virus superna-
pernatants were filtered through a 0.45-mm cellulose ace- tant was prepared as described above, except BCS was
tate filter (Fisher). After filtration, 10% sterile bovine calf not added after filtration. Virus was pelleted by high
serum (BCS) was added and the supernatants were speed centrifugation (15,000 g) for 2 hr at 4 7 (starting
stored at 47. The activity of virus stocks was monitored by material). The pellets were resuspended in 10 mM Tris/
EBNA staining (Reedman and Klein, 1973) and Western 150 mM NaCl/100 mg/ml bacitracin (Calbiochem) (TNB)
analysis of LMP-1 expression in infected BJAB cells (see buffer, pH 7.3, and layered onto two 12-ml discontinuous
below). dextran T-10 (Pharmacia) gradients (equal volumes of 5,
10, 15, and 30%, dissolved in TNB buffer). Dextran gradi-
Infection of cells ents were ultracentrifuged in an SW40 rotor at 20,700
rpm (76,000 g) for 1 hr at 47. The virus band was removedBJAB cells were incubated at 377 with viral supernatant
from the 15 to 30% interface by side-puncture with aat a density of 2 1 105 cells per ml for 1 hr (unless
syringe and 22-gauge needle. The dextran-purified virusotherwise noted) with continuous rocking. Infected cells
fraction was sonicated in 0.5 M urea (final concentration).were harvested by centrifugation (200 g), virus was re-
Solid sucrose was added to the virus fraction to a finalmoved, and cells were cultured in R10F for the duration
concentration of 50% (w/v). Two discontinuous sucroseof the experiment. Mock-infected cells were incubated
gradients were formed by layering equal volumes of 40,with R10C (rather than virus supernatant) and cultured
30, and 20% sucrose solutions (in TNB buffer) on top ofin R10F for the duration of the experiment.
the 50% sucrose-virus layer. The gradients were ultracen-The efficiency of infection was monitored by EBNA-
trifuged in an SW40 rotor at 25,300 rpm (112,700 g) forstaining of BJAB cells 72 hr after a 2- to 3-hr incubation
18 hr at 47. Virions floated to the 40 to 50% interface andwith virus supernatant and/or by determining the levels
were recovered as above. Sucrose was removed fromof LMP-1 expression in the same population of infected
the purified virus fraction by diluting the solution withcells by Western analysis (see below).
TNB buffer and centrifuging through a Centricon spin
column (Amicon; MWCO  100,000). Purified virus wasWestern analysis
concentrated in TNB buffer with a Microcon micro-
The expression of LMP-1 proteins was monitored by concentrator (Amicon; MWCO  100,000) and analyzed
Western blot analysis using an affinity-purified anti-LMP by Western analysis and electron microscopy.
antiserum raised against LMP-1’s carboxy-terminus
(Baichwal and Sugden, 1989). Cell lysates were sub- Electron microscopy of purified virus
jected to electrophoresis through a 10% SDS–polyacryl-
Pelleted B958 supernatant (starting material), dextran-amide gel and transferred to nitrocellulose. Nitrocellu-
purified, or sucrose-purified virus fractions were viewedlose blots were blocked with PBS/0.05% Tween 20/1%
by electron microscopy using negative-staining methods.Carnation instant nonfat milk and stained with a 1:100
Two microliters of each fraction were adsorbed onto car-dilution of anti-LMP antibody (in the same buffer) fol-
bon-coated grids and washed/stained with 2% phospho-lowed by 1:1000 dilution of an alkaline phosphatase-con-
tungstate.jugated goat anti-rabbit antibody (Sigma). Blots were de-
veloped with nitroblue tetrazolium and 5-bromo-4-chloro-
Immunoelectron microscopy of EBV virions
3-indolyl phosphate (Sigma). Prestained molecular
weight markers (Novex) consisted of myosin heavy chain Virus from TPA/butyrate-induced B958 cells was pel-
leted as described above (starting material) and resus-(250 kDa), bovine serum albumin (98 kDa), glutamic dehy-
drogenase (64 kDa), alcohol dehydrogenase (50 kDa), pended in 0.2 ml distilled water. Pelleted material was
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nebulized onto several carbon-coated grids, blocked for
30 min at room temperature with 0.1% BSA/0.1% Tween
20, and stained for 45 min at room temperature with a
1:10 dilution of affinity-purified anti-LMP-1 antisera (in the
same buffer), washed extensively with 0.1% BSA/0.1%
Tween 20, and incubated in a 1:10 dilution of 10 nm
protein A-colloidal gold (Sigma). Grids were extensively
washed and stained with 2% potassium phosphotung-
state. A matched irrelevant primary antibody (anti-TGF-
a) was used to confirm that the staining observed with
anti-LMP1 antisera was specific for epitopes encoded
by LMP-1’s carboxy-terminus.
FIG. 2. Detection of LMP-1 proteins in infected BJAB cells. BJAB cells
were infected with B958 virus for 1 hr at 377 and then grown in R10F
for designated times and harvested for Western analysis. Extracts fromPurification of GST–LMP-1 fusion protein
105 cells were resolved on a 10% polyacrylamide gel, transferred to
nitrocellulose, and stained with a polyclonal, affinity-purified anti-LMP-
p2036.1 was grown in 50 ml Luria-Bertani (LB) media 1 antibody, as described under Materials and Methods. B958 cells,
plus 100 mg/ml ampicillin overnight at 377 with agitation extract of 2.5 1 104 cells from the EBV-positive virus producer cell line
B958 (see Materials and Methods) included as a marker for both LMP-at 250 rpm. The overnight culture was diluted up to 500
1 proteins; hrs postinfection, hours postinfection when cells were har-ml in LB plus ampicillin and grown to an OD600  0.4.
vested; BJAB cells, extract of mock-infected (72 hr) BJAB cells. PositionsExpression of the fusion protein was induced by addition
of the 98- and 50-kDa molecular weight markers are shown to the side
of isopropylthio-b-D-galactoside (IPTG) (Sigma) to 1 mM of the blot. Upper arrow, full-length LMP-1 protein; lower arrow, lytic
and the incubation was continued at 377 for 3 hr. The LMP-1 protein. The 64-kDa band observed at 48 and 72 hr postinfec-
tion is a cellular cross-reacting protein whose expression is inducedbacterial culture was pelleted by centrifugation and the
variably by EBV infection.bacteria were lysed. The crude bacterial supernatant
was incubated overnight with glutathione-agarose beads
with rocking at 47; the beads were washed, and the fusion
RESULTSprotein was eluted with 5 mM glutathione. Following dial-
ysis against 20 mM HEPES buffer, the purity of the fusion The lytic LMP-1 protein is detected early after
protein was confirmed by resolving samples on a 10% infection
polyacrylamide gel and staining with Coomassie blue or
Both the lytic and the full-length LMP-1 proteins weretransferring to nitrocellulose and staining with anti-LMP-
detectable in EBV-infected BJAB (EBV-negative B1 antibody as described above. A Bradford assay was
lymphoma) cells (Fig. 2). The antisera used in these stud-performed to determine protein concentration (Bio-Rad).
ies was raised against the carboxy terminus of LMP-1,
and thus recognizes both forms of LMP-1 (Baichwal and
Estimation of the number of lytic LMP-1 molecules Sugden, 1989). Interestingly, the level of the lytic LMP-1
per virion protein remained constant up to 48 hr postinfection and
was difficult to detect by 72 hr postinfection, whereas
In order to estimate the number of lytic LMP-1 mole- the full-length protein increased between 24 and 48 hr
cules per virion, it is necessary to know the number of postinfection and then remained constant. We generally
lytic LMP-1 molecules per infected cell and the number detect full-length LMP-1 expression in infected BJAB
of virions per infected cell. The number of lytic LMP-1 cells within 12–72 hr postinfection; the variability in kinet-
molecules per infected cell following a 1-hr infection ics of LMP-1 detection depends on the virus preparation
were determined as follows. A standard curve of serial and/or condition of cells used (unpublished observa-
fourfold dilutions of the GST–LMP-1 fusion protein was tions). The higher molecular weight band (64 kDa) ob-
generated and compared to the lytic LMP-1 protein from served 48 and 72 hr postinfection represents a cellular
two independent extracts of B958-infected BJAB cells (1 cross-reacting protein detected in BJAB cells whose ex-
hr postinfection) by Western analysis using anti-LMP-1 pression is dependent upon cellular protein synthesis
antisera. Blots were quantitated using the ‘‘Quantity One’’ and is induced variably by EBV infection (see Figs. 2–5,
program from PDI and a linear standard curve was gener- 8, and legends). The differences in levels of the two LMP-
ated. The number of virions per infected cell was esti- 1 proteins prompted us to investigate further the kinetics
mated based on an empirically determined infection effi- of LMP-1 expression. BJAB cells were incubated with
ciency of 50% (% EBNA-positive cells following 72-hr in- B958 virus for 1 hr (see Materials and Methods), after
fection), and an estimated multiplicity of infection of one which the virus was removed and cells were grown for
the indicated time points. These initial experiments re-infectious particle per cell.
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FIG. 3. Detection of lytic LMP-1 shortly after infection of BJAB cells with B958 virus. BJAB cells were infected with B958 virus and subjected to
Western analysis using the anti-LMP-1 antisera as described under Materials and Methods. (A) Extracts from BJAB cells infected for 1 hr and grown
in R10F for up to 72 hr. hrs postinfection, hours postinfection when cells were harvested; B958 cells, extract of 2.5 1 104 cells from the EBV-positive
virus producer cell line B958 included as a marker for both LMP-1 proteins. (B) Extracts from BJAB cells infected for 10–60 min and immediately
harvested for Western analysis. BJAB cells, extract from mock-infected (60 min) and harvested immediately; B958 cells, as in (A). Unless otherwise
indicated, all lanes contain the equivalent of 105 cells; B958, 2.5 1 104 cells per lane. Positions of the 98- and 50-kDa molecular weight markers
are shown to side of blot. Upper arrow, full-length LMP-1 protein; lower arrow, lytic LMP-1 protein. The 64-kDa immunoreactive band is a cross-
reacting cellular protein and is observed in uninfected BJAB cells (see also Fig. 2).
vealed that the lytic LMP-1 protein was present as early
as 1 hr postinfection, whereas the full-length LMP-1 pro-
tein was not detectable until 72 hr postinfection (Fig.
3A). The detection of the lytic LMP-1 protein within 1
hr postinfection suggested its presence in the infecting
virion. We determined how early after infection the lytic
LMP-1 protein could be detected by infecting BJAB cells
with B958 virus for only 10–60 min and immediately har-
vesting for Western analysis. Although the signal is faint,
the lytic LMP-1 protein was reproducibly detectable as
early as 10 min postinfection (Fig. 3B), and maximal lev-
els were observed between 30 and 40 min postinfection
FIG. 4. The lytic LMP-1 protein is detectable in cells infected at 07 (n 3 independent infections). The level of the lytic LMP-
with B958 virus. BJAB cells were infected with B958 virus for 1–6 hr 1 protein at 40 min postinfection (Fig. 3B) was similar to
at 07. Infected cells were harvested for Western analysis using anti-
that detected at 1 hr postinfection (Fig. 3A).LMP-1 antibody, as described under Materials and Methods. BJAB
cells, extract of mock-infected BJAB cells (grown in R10C at 07 for Immunofluorescence analysis confirmed that the LMP-
duration of time course); B958 cells, cell extract of the EBV-positive 1 immunoreactivity in infected cells observed by Western
virus producing cell line B958 included as a marker for both LMP-1 analysis was cell-associated (not shown). All B958 virus
proteins; hrs postinfection at 07, duration of incubation with B958 virus.
supernatants used for B-cell infections (n  14) resultedLanes contain 105 cell equivalents, except B958 which contains 2.5 1
in the detection of the lytic LMP-1 protein within 1 hr of104 cell equivalents. Position of 98-, 64-, and 50-kDa molecular weight
markers are indicated. Upper arrow, full-length LMP-1 protein; lower infection (and as early as 10 min postinfection; Fig. 3B).
arrow, lytic LMP-1 protein (See legend to Fig. 2 and text for description In no case was the full-length LMP-1 protein observed
of 64-kDa cross-reacting band). This figure represents data from a at such early time points. We have detected full-lengthsingle Western blot, which was photographed and then individual lanes
LMP-1 as early as 12 hr postinfection in some experi-were rearranged so that irrelevant data could be omitted (all lanes
were developed together under identical conditions). ments, but never earlier. The kinetics of lytic LMP-1 de-
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FIG. 5. Detection of the lytic LMP-1 protein in cycloheximide-treated BJAB cells infected with B958 virus. BJAB cells were preincubated for 1 hr
in R10C with (/) or without (0) 10 mg/ml cycloheximide, followed by infection with B958 virus for 1 hr with or without cycloheximide. Virus was
removed and cells were further incubated in R10F with or without cycloheximide until the time of harvest. Cell lysates were analyzed by Western
analysis with anti-LMP-1 antisera. The described cycloheximide treatment resulted in inhibition of protein synthesis by 99% (data not shown). hrs
postinfection, hours after addition of virus to cells (time of harvest); Lane 0, untreated and uninfected BJAB cells; BJAB cells, extract of BJAB cells
which were mock-infected (24 hr) without cycloheximide; B958 cells, extract of 2.5 1 104 cells of the EBV-positive cell line B958, included as a
marker for both LMP-1 proteins. All lanes contain 105 cell equivalents unless otherwise indicated. Positions of 98-, 64-, and 50-kDa molecular weight
markers are indicated. Upper arrow, full-length LMP-1 protein; lower arrow, lytic LMP-1 protein. (Detection of the 64-kDa cross-reacting protein
is dependent upon cellular protein synthesis.)
tection correlate well with the kinetics of virus binding virus internalization, BJAB cells were incubated with B958
virus for up to 6 hr at 07 and thereafter harvested forto the cell at 377 (Nemerow and Cooper, 1984), sug-
gesting that the lytic LMP-1 detected in the cell shortly Western analysis (Fig. 4). Parallel infections were per-
formed at 377 and results were identical to those shownafter infection is derived from the infecting virion.
in Fig. 3A (data not shown). The level of the lytic LMP-1
detected by 1 hr postinfection was lower in cells infectedPresence of lytic LMP-1 does not require virus
at 07 than in cells infected at 377 (Figs. 3 and 5), presum-internalization
ably due to altered kinetics of virus binding at reduced
If the lytic LMP-1 protein preexists in the virion, then temperature. The level of the lytic LMP-1 protein detected
its appearance in the cell after infection should be inde- after 6 hr of infection at 07 is similar to that observed
pendent of virus internalization. Accordingly, the lytic after 1 hr infection at 377. From these data, we conclude
LMP-1 protein should be detectable in cells infected at that the presence of lytic LMP-1 does not require virus
temperatures that prohibit virus entry and subsequent internalization. These data are consistent with a model
viral gene expression. Immunoelectron microscopic in which the lytic LMP-1 protein is present in the virion
analysis of primary B-cells infected with B958 virus dem- and is incorporated into the cell upon infection.
onstrated that only 20% of virus particles remain at the
Detection of the lytic LMP-1 protein in infected cellscell surface 5 min after infection at 377, whereas 90%
is independent of protein synthesisof virus particles remain at the cell surface after a 1-hr
infection at 47 (Nemerow and Cooper, 1984). To deter- If the lytic LMP-1 protein preexists in the virion, its
presence in the infected cell should be independent ofmine if the presence of the lytic LMP-1 in the cell required
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protein synthesis. Therefore, infections were performed
in the presence of cycloheximide, a protein synthesis
inhibitor. BJAB cells were preincubated for 1 hr in the
presence or absence of 10 mg/ml cycloheximide, fol-
lowed by infection with B958 virus supernatant for 1 hr.
Virus was removed and cells were grown in culture for
the indicated time periods (Fig. 5). Cycloheximide was
included for the duration of the infection and subsequent
growth in culture. Treatment of cells with 10 mg/ml cyclo-
heximide for 1 hr was sufficient to inhibit cellular protein
synthesis by 99% (assayed by [35S]methionine incorpo-
ration into TCA-precipitable material, data not shown).
The presence of the lytic LMP-1 protein was independent
of protein synthesis since it was detectable in cells
treated with or without cycloheximide (Fig. 5). The levels
of lytic LMP-1 were higher in cycloheximide-treated cells
than in untreated cells at later time points (see 12 and
24 hr postinfection). The increase in levels of the lytic
protein in cycloheximide-treated cells was likely to result
from a increase in the half-life of the protein, since the
turnover of LMP-1 requires ongoing protein synthesis
(Martin and Sugden, 1991a). In contrast, the full-length
FIG. 6. Enrichment of the LMP-1 proteins in virus purified from B958LMP-1 protein was detectable at low levels by 24 hr
supernatant. Viral supernatant from TPA/butyrate-treated B958 cellspostinfection in cells that were not treated with cyclohexi-
was purified by density centrifugation as described under Materialsmide, but undetectable in cycloheximide-treated cells
and Methods. Samples from each fraction were subjected to Western
(Fig. 5). As mentioned above, the kinetics of appearance analysis or electron microscopy. (A) Western analysis of fractions. A,
of full-length LMP-1 in infected cells depends on the titer dextran fraction (1% of virus band); B, sucrose fraction (12% of virus
band); B958 cells, extract from 105 B958 cells. Positions of 68- and 43-of virus as well as the condition of cells. The toxicity of
kDa molecular weight markers are shown to side of blot. Upper arrow,prolonged cycloheximide treatment (i.e., longer than 24
full-length LMP-1 protein; lower arrow, lytic LMP-1 protein; asterisk,hr) precluded treatment of infected cells with cyclohexi-
LMP-1 immunoreactive protein, (LMP-1a (see text)). (B) Electron micro-
mide for time periods long enough to observe high levels graphs of unfixed, negatively stained virions. 1, dextran fraction; 2,
of full-length LMP-1 treatment in untreated cells (greater sucrose fraction. Scale bar, 0.2 mm. These results are representative
of two independent purified virus preparations.than 24 hr postinfection). Identical results were obtained
when a different inhibitor, anisomycin, was used in place
of cycloheximide (data not shown). These results indicate
that the full-length LMP-1 protein is synthesized de novo ods). It was difficult to isolate EBV virion preparations that
were completely free of copurifying membrane vesiclesin the infected cell, and the lytic LMP-1 protein preexists,
presumably in the virion, and is carried into the cell upon derived from the virus-producing cell. The inability to iso-
late purified herpesvirions from copurifying small mem-infection.
By comparison of the levels of lytic LMP-1 in cells brane vesicles is well documented (Spear and Roizman,
1972). The problem of membrane contamination isfollowing 1 hr infection to a standard curve generated
with a GST–LMP-1 fusion protein (as described under greater with purification of EBV virions (EBV does not
efficiently release virus) because of the large amount ofMaterials and Methods), we estimate there to be at least
100 lytic LMP-1 molecules/virion. This number is based starting material required to ensure sufficient yield of
pure virus. Nonetheless, electron microscopic (EM) anal-on an infection efficiency of 50% (50% of cells infected
as determined by EBNA-staining), and an estimated mul- ysis of density fractions indicated that virions were
greatly enriched in the final sucrose density fraction (Fig.tiplicity of infection of one infectious particle per cell.
6B). Enrichment of virions following fractionation was
particularly evident when EM micrographs of undilutedThe lytic LMP-1 protein is enriched in purified virion
sucrose fractions (as shown in Fig. 6B, micrograph 2)preparations
were compared to micrographs of starting material (not
shown), which required at least 100-fold dilution in orderTo obtain direct evidence that the lytic LMP-1 protein
is associated with EBV virions, virus was purified from to identify virions amidst the background of cell debris
(Materials and Methods, compare Figs. 6 and 7).supernatant obtained from TPA/butyrate-treated B958
cells by density centrifugation (see Materials and Meth- Western analysis of starting material (not shown) and
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FIG. 7. Immunoelectron microscopic localization of LMP-1 in B958 virus supernatant. Virus from TPA/butyrate-induced B958 cells was pelleted
by centrifugation and nebulized onto carbon-coated grids, as described under Materials and Methods. Grids were stained with anti-LMP-1 antisera
(1:10), followed by 10 nm protein A-colloidal gold (1:10), and counterstained with 2% phosphotungstate. Specificity of staining for LMP-1 was
confirmed with a matched, irrelevant (anti-TGF-a) rabbit antibody. Scale bar, 0.1 mm.
density fractions (Fig. 6A) indicated that the lytic LMP-1, length LMP-1 protein is present in membrane vesicles
that copurify with virions over sucrose.full-length LMP-1, and an 55-kDa form of LMP-1 (aster-
isk) are present in all fractions. The identity of the 55-
Lytic LMP-1 protein is detectable in cells infectedkDa form of LMP-1 is unknown; we shall refer to this
with another strain of EBVprotein as LMP-1a. Although both the lytic and full-length
LMP-1 proteins could be detected in uninduced B958 To ensure that the early detection of the lytic LMP-1
cells (Figs. 2–6, 8–9), the LMP-1a protein was observed in infected cells was not a phenomenon restricted solely
only in B958 supernatants from TPA-induced cells (not to the B958 strain of EBV, infection of BJAB cells with
shown) and purified virus fractions (Fig. 6A). All three supernatant from HH514 cells was performed. HH514
LMP-1 proteins copurified with virus in the sucrose frac- cells harbor a nontransforming strain of EBV that carries
tion. The ratio of full-length LMP-1 to lytic LMP-1 was a deletion encompassing EBNA-2 and a portion of the
lower in the purified sucrose fraction (£1) than in the EBNA-LP coding regions (Bornkamm et al., 1982). Due
partially purified dextran fraction (1), suggesting that to the deficiency of EBNA-2 expression, full-length LMP-
the lytic LMP-1 is enriched, relative to the full-length 1 levels in HH514 cells are low relative to levels in B958
LMP-1, in the final sucrose fraction (Fig. 6A). EM analysis cells. Furthermore, BJAB cells infected with HH514 virus
revealed that virus particles were significantly enriched supernatant express little or no full-length LMP-1 (unpub-
in the final sucrose fraction, although copurifying mem- lished observations). BJAB cells were infected with su-
brane vesicles were still observed (Fig. 6B). Immuno-EM pernatant from TPA/butyrate-induced HH514 cells for 3
analysis of unpurified virus supernatants showed that hr at 377 and analyzed by Western analysis using anti-
EBV virions, and contaminating membrane fragments, LMP-1 antisera. The lytic LMP-1 protein was detected in
were specifically labeled with anti-LMP-1 antisera (Fig. infected cells, as was a 48-kDa LMP-1 immunoreac-
7). Attempts to label samples with immunogold following tive, EBV-specific, band of unknown identity (Fig. 8). Sub-
sucrose fractionation were unsuccessful (perhaps due sequent experiments with cycloheximide and anisomycin
to urea treatment of the dextran fraction prior to sucrose revealed that the presence of both the 48-kDa and lytic
fractionation); neither virions nor membrane vesicles LMP-1 proteins in HH514-infected cells was independent
could be specifically labeled with anti-LMP-1 antisera of host cell protein synthesis (data not shown). Although
(not shown). Taken together, and in context with data the lytic LMP-1 protein was detected in cells infected
from short term B-cell infections (Figs. 2–5), these results with different HH514 virus preparations (n 3), the levels
are consistent with a model in which the lytic LMP-1 of lytic LMP-1 detected in cells within 1–3 hr of infection
were lower than those observed in cells infected withprotein is present in the EBV virion, whereas the full-
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B958 virus (compare Figs. 3A and 8). These results are
consistent with the lytic LMP-1 protein being present in
virions derived from at least two strains of EBV.
Lytic LMP-1 protein expression is induced by TPA/
butyrate in B958 and HH514 cells
The EBV virion derives its envelope from cellular mem-
branes of B958 cells (from which virus is derived) which
contain both forms of LMP-1. We asked if the lytic LMP-
1 is incorporated into the virion nonspecifically as a func-
tion of its subcellular localization and high level of ex-
pression in TPA/butyrate-induced cells. If the lytic LMP-
1 is incorporated into virions by a specific mechanism,
then virus harvested from cells that express high levels
of full-length LMP-1, as well as lytic LMP-1, should only
incorporate the lytic protein. Therefore, we investigated
the kinetics of expression of both LMP-1 proteins in virus-
producing cells. B958 and HH514 cells were induced
with TPA/butyrate for up to 72 hr as described under
FIG. 9. Kinetics of LMP-1 expression in B958 and HH514 cells afterMaterials and Methods, and cell lysates were subjected
induction by TPA/butyrate. B958 cells (A) and HH514 cells (B) wereto Western analysis. Consistent with previous results
incubated with 20 ng/ml TPA and 3.5 mM sodium butyrate for the
(Baichwal and Sugden, 1987), treatment of B958 cells designated times. Cell extracts were analyzed by Western analysis
with TPA/butyrate resulted in induction of the lytic LMP- using anti-LMP-1 antisera. hrs following TPA/butyrate addition, time of
harvest following addition of TPA/butyrate (T 0, untreated cells); B9581 protein by 48 hr with no significant change in levels of
cells, cell extract of 2.5 1 104 cells from the EBV-positive cell line,full-length LMP-1 (Fig. 9A). Interestingly, similar treatment
B958, included as a marker for LMP-1 proteins. All lanes contain 2 1of HH514 cells resulted in upregulation of both the lytic
104 cell equivalents, unless otherwise indicated. Positions of 98-, 64-,
and full-length LMP-1 proteins. Uninduced HH514 cells 50-, and 36-kDa molecular weight markers are shown to the side of
express very low levels of LMP-1 proteins (T  0), and the blot. Upper arrow, full-length LMP-1 protein; lower arrow, lytic LMP-
1 protein.upregulation of full-length and lytic LMP-1 was detect-
able within 12 and 24 hr postinduction, respectively.
Higher levels of full-length LMP-1, relative to levels of
lytic LMP-1 protein, were observed by 72 hr postinduc-
tion. The different levels of LMP-1 proteins observed 72
hr postinduction may result from different rates of induc-
tion, or may reflect a difference in levels of full-length vs
lytic LMP-1 protein levels in the uninduced cells (T  0).
A 48-kDa immunoreactive protein is also induced in
HH514 cells (presumably the same 48-kDa protein de-
tected in the HH514 virion, Fig. 8). The lytic LMP-1 mRNA
is upregulated in TPA/butyrate-induced B958 and HH514
cells, and pulse–chase analyses indicate that neither
the lytic LMP-1 protein nor the 48-kDa immunoreactive
FIG. 8. The lytic LMP-1 protein is detectable in BJAB cells infected protein are derived proteolytically from the full-length
with HH514 virus. BJAB cells were infected with HH514 virus for 3 hr LMP-1 in either cell line (data not shown). The 48-kDa
at 377 and sonicated cell lysates were subjected to Western analysis protein may represent a posttranslationally modified form
as described under Materials and Methods. BJAB cells, extract of
of the lytic LMP-1 protein. In addition, we have detectedmock-infected BJAB cells (grown in R10C at 377 for duration of time
the lytic LMP-1 protein in BJAB cells infected for 1 hrcourse); B958 cells, cell extract of the EBV-positive virus producing
cell line B958 included as a marker for both LMP-1 proteins; hrs with virus supernatant from uninduced B958 cells (not
postinfection with HH514, duration of incubation with HH514 virus. shown) that generally express higher levels of full-length
Lanes contain 105 cell equivalents, except B958 which contains 2.5 LMP-1 than lytic LMP-1 (Fig. 9A, lane 0; see also B9581 104 cell equivalents. Position of 98- and 50-kDa molecular weight
controls, Fig. 2–5, 8). These results suggest that a spe-markers are indicated. Upper arrow, full-length LMP-1 protein; lower
cific mechanism is involved in incorporation of the lyticarrow, lytic LMP-1 protein (See legend to Fig. 2 and text for description
of 64-kDa cross-reacting band). LMP-1 protein into the virion, since both forms of LMP-
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1 are expressed in cells from which virus is derived, yet of primary B-cells (not shown). In addition, our results
were obtained from cells infected with virus supernatantonly the lytic LMP-1 is detected shortly after infection.
from TPA/butyrate-induced B958 cells which express
significantly greater levels of lytic LMP-1 than full-lengthDISCUSSION
LMP-1 protein (Fig. 9A). Although it is possible that the
levels of LMP-1 protein expressed in the cell from whichEpstein–Barr virus expresses two related membrane
proteins (LMP-1 and lytic LMP-1) from the BamHI N re- virus is derived may dictate which form of LMP-1 is pres-
ent in the virion, two lines of evidence argue againstgion of its genome, each of which is specified by mRNAs
arising from the differential activity of distinct promoters this possibility. First, we observed only the lytic LMP-
1 protein early after infection (within 1 hr) when virus(Hudson et al., 1985). LMP-1 (referred to here as the full-
length LMP-1 protein), has been shown to have profound supernatant from uninduced B958 cells (which express
significantly greater levels of full-length LMP-1 than lyticeffects on the growth of cells in culture and is one of
the four latent gene products shown to be essential for LMP-1) was used rather than TPA/butyrate-induced virus
supernatant. Second, detection of the lytic LMP-1 proteinimmortalization of B-cells by EBV. The lytic LMP-1 protein
is an amino-terminally truncated version of LMP-1 whose in infected cells early (within minutes) after infection was
independent of the ratio of levels of LMP-1 and lyticexpression is associated with EBV’s lytic cycle. Although
the sequence of the lytic LMP-1 is identical to the car- LMP-1 proteins expressed in virus-producing cells (Figs.
9A and 9B). Our Western analyses indicate that the LMP-boxy-terminal 257 residues of the full-length LMP-1 pro-
tein, genetic analysis of LMP-1 has revealed few, if any, 1 immunoreactivity observed early after infection is
clearly associated with the lytic LMP-1 protein (Figs. 2common biochemical or biological properties. At this
time, there are no known functions assigned to the lytic and 3). Western analysis of purified virions reveals the
presence of both the lytic LMP-1 and the full-length LMP-LMP-1 protein. Here we present results that provide in-
sight into possible roles for the lytic LMP-1 in the virus life 1 proteins (Fig. 6A, lane B). EM analysis indicates that
while not completely pure, the virions in the sucrosecycle. The lytic LMP-1 protein was detectable by Western
analysis in BJAB cells infected for only 10 min with B958 fraction are enriched relative to the dextran fraction with
respect to membrane vesicles. Comparison of the levelsvirus. The time course of appearance of the lytic protein
paralleled the kinetics of virus binding to the cell at both of LMP-1 proteins in the sucrose fraction relative to lev-
els in the dextran fraction suggest an enrichment of the37 and 07 (Figs. 2–5). The presence of the lytic LMP-1
protein early after infection (within minutes) does not lytic LMP-1 protein relative to the full-length LMP-1 pro-
tein (Fig. 6C), and this enrichment correlates with anrequire host cell protein synthesis or virus internalization,
suggesting strongly that the lytic LMP-1 protein preexists enrichment of virions relative to membrane vesicles (Fig.
6B, compare 1 and 2). Immuno-EM analysis of virus su-in the virion and is carried into the cell upon infection.
Consistent with this conclusion is the selective enrich- pernatants demonstrate that EBV virions can be specifi-
cally labeled with anti-LMP-1 antisera (Fig. 7). Thesement of the lytic LMP-1 protein in purified EBV virion
preparations (Fig. 6). We propose a model in which the results, together with results from Western analyses of
infected cells in which only the lytic LMP-1 protein islytic LMP-1 protein plays a role in early events during B-
cell infection and/or may contribute to the lytic phase of present shortly after infection (Figs. 2– 5), suggest
strongly, but do not prove, that the lytic LMP-1 proteinEBV’s life cycle.
The full-length LMP-1 protein was consistently de- is present in the EBV virion, while the full-length LMP-1
is present in the contaminating membranes derived fromtected in B958-infected cells between 24 and 72 hr post-
infection (Figs. 2, 3A, and 5, and data not shown), but the virus-producing B958 cells. Studies in progess are
designed to test this model further.was never detected earlier than 12 hr. Results from
cycloheximide experiments indicate that detection of the The lytic LMP-1 protein was also detected in BJAB
cells infected with the HH514 strain of EBV at very earlyfull-length LMP-1 protein is dependent on host cell pro-
tein synthesis, demonstrating that the full-length LMP-1 time points (Fig. 8). The lower levels of lytic LMP-1 in
HH514-infected BJAB cells relative to levels in B958-in-protein is synthesized de novo in the infected cell. Our
results differ from those of Mann and Thorley-Lawson fected BJAB cells are consistent with the relative levels
of lytic LMP-1 protein induced with TPA in the respective(Mann et al., 1985) in that we found no evidence for the
presence of full-length LMP-1 in the virion. Rather, we virus producing cell lines (Fig. 9) and may be due to
differences in cellular factors and/or the different virusobserve only the lytic LMP-1 protein in cells early after
infection and, by inference, in the isolated virion itself. strains. Presumably the levels of lytic LMP-1 associated
with the virion would reflect the levels of protein ex-Unlike primary B-cells infected by the Thorley-Lawson
group, the results of experiments reported here were pressed in the cell from which the virus is derived. It is
noteworthy that the B958 strain of EBV efficiently trans-obtained from EBV-infected BJAB cells. However, we
have obtained identical results following B958 infection forms B-cells and infection with this strain results in the
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detection of high levels of the lytic LMP-1 in infected virus is a small virion protein that functions as a pH-
dependent ion channel when the virus is taken into lowcells shortly after infection, whereas the HH514 strain
is nontransforming and lower levels of lytic LMP-1 are pH endosomes after infection. M2 is responsible for ini-
tiating the uncoating process of the virus. The M2 proteindetected at early time points postinfection. Further stud-
ies are needed to determine if the lytic LMP-1 protein has a single transmembrane domain and forms homotet-
ramers via ‘‘extracellular’’ disulfide linkages, therebyhas any effects on the efficiency of immortalization by
EBV, and if EBNA-2 expression in HH514 cells can effect forming the channel pore. While the M2 protein is ex-
pressed abundantly at the plasma membrane in the in-the levels of lytic LMP-1 protein in the virion.
The contribution of the lytic LMP-1 protein to the virus fected cell (106 –107 molecules), there are only 20– 60
molecules present per virion (reviewed in Lamb et al.,life cycle is unknown. Evidence suggests that this protein
plays a role in some aspect of the lytic cycle or in early 1994). It is possible that the lytic LMP-1 functions in a
manner similar to M2 protein as the two proteins areevents following infection (Baichwal and Sugden, 1987;
Rowe et al., 1987, 1992; and our results). The association comparable in size and abundance in their respective
virions.of the lytic LMP-1 with lytic replication in B958 cells is
strong evidence for a role in the lytic cycle. Both the It is equally possible that the lytic LMP-1 may play a
role in early cellular events triggered by EBV infection.lytic LMP-1 mRNA and protein are upregulated in TPA-
induced B958 cells, and B958 cells actively undergoing The binding of EBV to the cellular CR2 protein triggers
a signal transduction cascade, which is independent ofthe lytic cycle express high levels of the lytic LMP-1
protein (Baichwal and Sugden, 1987; Hudson et al., 1985; viral gene expression, involving tyrosine phosphorylation
and phosphatidylinositol 3-kinase activation (Sinclair andRowe et al., 1987; and our unpublished observations).
Similarly, other virus producer cell lines (HH514, Akata, Farrell, 1995). Some of these signaling events appear to
be critical for the evolution of the appropriate pattern ofand M-ABA) (Fig. 9; our unpublished observations; Boos
et al., 1987; Rowe et al., 1992) express elevated levels viral gene expression, and viral gene expression appears
to be essential for the maintained cycling of infected B-of the lytic LMP-1 protein both spontaneously and upon
induction of the lytic cycle with chemical inducers. EBV- cells (Sinclair and Farrell, 1995). Since the lytic LMP-1
protein is present in the infected cell at the time suchpositive B-cell lines that are nonpermissive for virus repli-
cation and virus release (or that inefficiently enter the signaling events occur, it may play a role in modulating
cellular signaling pathways, either positively or nega-lytic cycle) do not express the lytic LMP-1 protein, and
induction of the lytic cycle with chemical inducers results tively, shortly after infection. It is not yet known if the lytic
LMP-1 protein, like the full-length protein, can interactin variable upregulation of the full-length LMP-1 with no
effect on levels of the lytic LMP-1 protein (Boos et al., with TRAF proteins. However, since LMP-1’s carboxy-
terminus is sufficient for this interaction (when assayed1987; Rowe et al., 1987; and our unpublished observa-
tions). Together, these observations support a role for by yeast two hybrid analysis) (Mosialos et al., 1995), and
since the entire carboxy-terminal cytoplasmic domain isthe lytic LMP-1 protein in the lytic cycle, and our findings
which suggest that this protein is in the EBV virion are encoded by the lytic LMP-1 protein, it is possible that
the lytic LMP-1 can bind to and regulate the activity ofconsistent with a possible role in virus egress, or per-
haps in early events following infection. TRAF proteins or prevent interaction of the full-length
LMP-1 protein with TRAF proteins. Experiments are inSince little is known about the lytic LMP-1 protein,
studies of other viruses and their activities may prove progress to ask where, if at all, the lytic LMP-1 protein
acts in these pathways.useful in generating models to describe possible func-
tions for this protein in EBV’s life cycle. The ICP47 protein Little is known about the function of the lytic LMP-1
protein. Although identical in sequence to the carboxy-of herpes simplex virus has been shown to be responsi-
ble for blocking antigen presentation at the cell surface terminus of LMP-1, the lytic LMP-1 shares few, if any, of
LMP-1’s biochemical and biological activities. The differ-by either retaining MHC class I molecules in the endo-
plasmic reticulum (ER) and/or Golgi or by inhibiting pep- ential expression/detection of the lytic LMP-1 in infected
B-cells and the association of the lytic LMP-1 with thetide transport across ER membranes (York et al., 1994).
Infection by two other herpesviruses (human and murine lytic cycle suggests a function distinct from that of LMP-
1. Genetic analysis of the lytic LMP-1 in the context ofcytomegaloviruses) has also been reported to block anti-
gen presentation by MHC class I molecules, but this the viral genome will provide insights into its function
and relevance to EBV’s life cycle.activity has not yet been assigned to a specific viral
protein(s) (Beersma et al., 1993; del Val et al., 1992). It is
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